Cargando…
Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada
OBJECTIVES: The similarity in retention of tumour necrosis factor inhibitors (TNFi) and tofacitinib (TOFA) was previously reported separately by the Ontario Best Practices Research Initiative and the Quebec cohort Rhumadata. However, because of small sample sizes in each registry, we aimed to confir...
Autores principales: | Movahedi, Mohammad, Choquette, Denis, Coupal, Louis, Cesta, Angela, Li, Xiuying, Keystone, Edward C, Bombardier, Claire, Investigators, OBRI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990670/ https://www.ncbi.nlm.nih.gov/pubmed/36878650 http://dx.doi.org/10.1136/bmjopen-2022-063198 |
Ejemplares similares
-
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis
por: Rahman, Proton, et al.
Publicado: (2016) -
Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022) -
Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis (RA): A Retrospective Study From Two Centers in Jeddah, Saudi Arabia
por: Alzahrani, Zeyad, et al.
Publicado: (2022) -
Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative
por: Li, Xiuying, et al.
Publicado: (2022) -
A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years
por: Jobanputra, Paresh, et al.
Publicado: (2012)